Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil.

Gurgel RQ, Cuevas LE, Vieira SC, Barros VC, Fontes PB, Salustino EF, Nakagomi O, Nakagomi T, Dove W, Cunliffe N, Hart CA.

Emerg Infect Dis. 2007 Oct;13(10):1571-3. doi: 10.3201/eid1310.070412.

2.

Rotavirus genotypes circulating in Brazil before national rotavirus vaccination: a review.

Gurgel RQ, Cunliffe NA, Nakagomi O, Cuevas LE.

J Clin Virol. 2008 Sep;43(1):1-8. doi: 10.1016/j.jcv.2008.04.010. Review.

PMID:
18567534
3.

Group A rotavirus genotypes and the ongoing Brazilian experience: a review.

Leite JP, Carvalho-Costa FA, Linhares AC.

Mem Inst Oswaldo Cruz. 2008 Dec;103(8):745-53. Review.

4.

Rotaviruses: is their surveillance needed?

Jain S, Vashistt J, Changotra H.

Vaccine. 2014 Jun 5;32(27):3367-78. doi: 10.1016/j.vaccine.2014.04.037. Review.

PMID:
24793942
5.
6.

Rotavirus vaccines and vaccination in Latin America.

Linhares AC, Bresee JS.

Rev Panam Salud Publica. 2000 Nov;8(5):305-31. Review.

PMID:
11190969
7.

The pentavalent rotavirus vaccine, RotaTeq.

Matson DO.

Semin Pediatr Infect Dis. 2006 Oct;17(4):195-9. Review.

PMID:
17055370
8.

Rotavirus disease and vaccination: impact on genotype diversity.

Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Bányai K, Rahman M, Zeller M, Beutels P, Van Damme P, Van Ranst M.

Future Microbiol. 2009 Dec;4(10):1303-16. doi: 10.2217/fmb.09.96. Review.

PMID:
19995190
9.

Current status of rotavirus vaccines.

Wang CM, Chen SC, Chen KT.

World J Pediatr. 2015 Nov;11(4):300-8. doi: 10.1007/s12519-015-0038-y. Review.

PMID:
26454434
10.

Rotarix®: vaccine performance 6 years postlicensure.

O'Ryan M, Lucero Y, Linhares AC.

Expert Rev Vaccines. 2011 Dec;10(12):1645-59. doi: 10.1586/erv.11.152. Review.

PMID:
22085167
11.

Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?

Matthijnssens J, Nakagomi O, Kirkwood CD, Ciarlet M, Desselberger U, Van Ranst M.

Expert Rev Vaccines. 2012 Nov;11(11):1347-54. doi: 10.1586/erv.12.105. Review.

PMID:
23249234
13.

Live attenuated human rotavirus vaccine, Rotarix.

Bernstein DI.

Semin Pediatr Infect Dis. 2006 Oct;17(4):188-94. Review.

PMID:
17055369
14.

Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Dóró R, László B, Martella V, Leshem E, Gentsch J, Parashar U, Bányai K.

Infect Genet Evol. 2014 Dec;28:446-61. doi: 10.1016/j.meegid.2014.08.017. Review.

PMID:
25224179
15.

Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012.

Rha B, Tate JE, Payne DC, Cortese MM, Lopman BA, Curns AT, Parashar UD.

Expert Rev Vaccines. 2014 Mar;13(3):365-76. doi: 10.1586/14760584.2014.877846. Review.

PMID:
24392657
Items per page

Supplemental Content

Support Center